These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30985528)

  • 61. Five-Year Cervical (Pre)Cancer Risk of Women Screened by HPV and Cytology Testing.
    Uijterwaal MH; Polman NJ; Van Kemenade FJ; Van Den Haselkamp S; Witte BI; Rijkaart D; Berkhof J; Snijders PJ; Meijer CJ
    Cancer Prev Res (Phila); 2015 Jun; 8(6):502-8. PubMed ID: 25776933
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening results.
    Schiffman M; Burk RD; Boyle S; Raine-Bennett T; Katki HA; Gage JC; Wentzensen N; Kornegay JR; Aldrich C; Tam T; Erlich H; Apple R; Befano B; Castle PE
    J Clin Microbiol; 2015 Jan; 53(1):52-9. PubMed ID: 25339396
    [TBL] [Abstract][Full Text] [Related]  

  • 63. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
    Gilham C; Sargent A; Kitchener HC; Peto J
    Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Risk for cervical intraepithelial neoplasia grade 3 or worse in relation to smoking among women with persistent human papillomavirus infection.
    Jensen KE; Schmiedel S; Frederiksen K; Norrild B; Iftner T; Kjær SK
    Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):1949-55. PubMed ID: 23019238
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Respective prevalence of high-risk HPVgenotypes in cervical neoplasia in Senegal.
    Diop-Ndiaye H; Sastre-Garau X; Drame A; Dembele B; Ba NN; Diop-Diongue O; Mbow M; Diakhaby MEB; Woto-Gaye G; Toure Kane C; Diop M
    J Med Virol; 2021 Aug; 93(8):5110-5117. PubMed ID: 33851737
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Approaches to triage optimization in HPV primary screening: Extended genotyping and p16/Ki-67 dual-stained cytology-Retrospective insights from ATHENA.
    Stoler MH; Baker E; Boyle S; Aslam S; Ridder R; Huh WK; Wright TC
    Int J Cancer; 2020 May; 146(9):2599-2607. PubMed ID: 31490545
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Incidence risk of cervical intraepithelial neoplasia 3 or more severe lesions is a function of human papillomavirus genotypes and severity of cytological and histological abnormalities in adult Japanese women.
    Hosaka M; Fujita H; Hanley SJ; Sasaki T; Shirakawa Y; Abiko M; Kudo M; Kaneuchi M; Watari H; Kikuchi K; Sakuragi N
    Int J Cancer; 2013 Jan; 132(2):327-34. PubMed ID: 22729477
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Human papillomavirus infections among women with cervical lesions and cervical cancer in Eastern China: genotype-specific prevalence and attribution.
    Zhang L; Bi Q; Deng H; Xu J; Chen J; Zhang M; Mu X
    BMC Infect Dis; 2017 Jan; 17(1):107. PubMed ID: 28143439
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Prevalence of genotype-specific HPV infection among women in France: implications for screening and vaccination].
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Gynecol Obstet Fertil; 2013 May; 41(5):305-13. PubMed ID: 23647817
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A cohort study of cervical screening using partial HPV typing and cytology triage.
    Schiffman M; Hyun N; Raine-Bennett TR; Katki H; Fetterman B; Gage JC; Cheung LC; Befano B; Poitras N; Lorey T; Castle PE; Wentzensen N
    Int J Cancer; 2016 Dec; 139(11):2606-15. PubMed ID: 27509172
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer.
    Guan P; Howell-Jones R; Li N; Bruni L; de Sanjosé S; Franceschi S; Clifford GM
    Int J Cancer; 2012 Nov; 131(10):2349-59. PubMed ID: 22323075
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Diagnostic accuracy of colposcopy in relation to human papillomavirus genotypes and multiple infection.
    Spinillo A; Gardella B; Chiesa A; Cesari S; Alberizzi P; Silini EM
    Gynecol Oncol; 2014 Sep; 134(3):527-33. PubMed ID: 25026638
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women.
    Aoyama-Kikawa S; Fujita H; Hanley SJB; Kasamo M; Kikuchi K; Torigoe T; Matsuno Y; Tamakoshi A; Sasaki T; Matsuura M; Kato Y; Dong P; Watari H; Saito T; Sengoku K; Sakuragi N
    Cancer Sci; 2018 Jun; 109(6):2003-2012. PubMed ID: 29660849
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long-term risk of cervical intraepithelial neoplasia grade 3 or worse according to high-risk human papillomavirus genotype and semi-quantitative viral load among 33,288 women with normal cervical cytology.
    Thomsen LT; Frederiksen K; Munk C; Junge J; Iftner T; Kjaer SK
    Int J Cancer; 2015 Jul; 137(1):193-203. PubMed ID: 25471319
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.
    Naucler P; Ryd W; Törnberg S; Strand A; Wadell G; Elfgren K; Rådberg T; Strander B; Forslund O; Hansson BG; Hagmar B; Johansson B; Rylander E; Dillner J
    J Natl Cancer Inst; 2009 Jan; 101(2):88-99. PubMed ID: 19141778
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional study in 10,669 Chinese women.
    Zhao X; Wu Q; Wang X; Fu Y; Zhang X; Tian X; Cheng B; Lu B; Yu X; Lan S; Lu W; Ma D; Cheng X; Xie X
    Clin Microbiol Infect; 2018 Dec; 24(12):1322-1327. PubMed ID: 29518562
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Human Papillomavirus Test for Triage of Japanese Women With Low-Grade Squamous Intraepithelial Lesions.
    Iwata T; Hasegawa T; Ochiai K; Takizawa K; Umezawa S; Kuramoto H; Ohmura M; Kubushiro K; Arai H; Sakamoto M; Motoyama T; Watanabe K; Aoki D
    Reprod Sci; 2015 Dec; 22(12):1509-15. PubMed ID: 26092278
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.
    Coutlée F; Ratnam S; Ramanakumar AV; Insinga RR; Bentley J; Escott N; Ghatage P; Koushik A; Ferenczy A; Franco EL
    J Med Virol; 2011 Jun; 83(6):1034-41. PubMed ID: 21503917
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prevalence and correlates of human papillomavirus genotypes among patients with cervical cancer and cervical intraepithelial neoplasia 3 in Israel.
    Bassal R; Rosin LS; Schvimer M; Schejter E; Ozeryansky B; Kulik S; Bachar R; Shapira H; Sandbank J; Cohen D; Keinan-Boker L
    J Low Genit Tract Dis; 2015 Apr; 19(2):161-4. PubMed ID: 25105719
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine.
    Ault KA; Joura EA; Kjaer SK; Iversen OE; Wheeler CM; Perez G; Brown DR; Koutsky LA; Garland SM; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Majewski S; Muñoz N; Sings HL; Harkins K; Rutkowski MA; Haupt RM; Garner EI;
    Int J Cancer; 2011 Mar; 128(6):1344-53. PubMed ID: 20949623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.